Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity

v3.21.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
As previously reported
Retroactive application of recapitalization
Common Shares
Common Shares
As previously reported
Common Shares
Retroactive application of recapitalization
Preferred Shares
Preferred Shares
As previously reported
Preferred Shares
Retroactive application of recapitalization
Additional Paid-in Capital
Additional Paid-in Capital
As previously reported
Additional Paid-in Capital
Retroactive application of recapitalization
Retained (Deficit)
Retained (Deficit)
As previously reported
Attributable to Non- controlling Interest
Attributable to Non- controlling Interest
As previously reported
Beginning balance (in shares) at Dec. 31, 2019       8,304,030 19,266,609 (10,962,579) 0 5,988,957 (5,988,957)              
Beginning balance at Dec. 31, 2019 $ 50,193 $ 50,193 $ 0 $ 0 $ 2 $ (2) $ 0 $ 1 $ (1) $ 77,431 $ 77,428 $ 3 $ (31,933) $ (31,933) $ 4,695 $ 4,695
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation expenses 416                 416            
Net loss (10,186)                       (9,282)   (904)  
Ending balance (in shares) at Mar. 31, 2020       8,304,030     0                  
Ending balance at Mar. 31, 2020 40,423     $ 0     $ 0     77,847     (41,215)   3,791  
Beginning balance (in shares) at Dec. 31, 2019       8,304,030 19,266,609 (10,962,579) 0 5,988,957 (5,988,957)              
Beginning balance at Dec. 31, 2019 50,193 50,193 0 $ 0 $ 2 $ (2) $ 0 $ 1 $ (1) 77,431 77,428 3 (31,933) (31,933) 4,695 4,695
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (18,939)                              
Ending balance (in shares) at Jun. 30, 2020       10,132,997     0                  
Ending balance at Jun. 30, 2020 39,749     $ 0     $ 0     85,926     (49,224)   3,047  
Beginning balance (in shares) at Dec. 31, 2019       8,304,030 19,266,609 (10,962,579) 0 5,988,957 (5,988,957)              
Beginning balance at Dec. 31, 2019 50,193 $ 50,193 $ 0 $ 0 $ 2 $ (2) $ 0 $ 1 $ (1) 77,431 $ 77,428 $ 3 (31,933) $ (31,933) 4,695 $ 4,695
Ending balance (in shares) at Dec. 31, 2020       24,883,024     0                  
Ending balance at Dec. 31, 2020 95,250     $ 0     $ 0     164,264     (69,014)      
Beginning balance (in shares) at Mar. 31, 2020       8,304,030     0                  
Beginning balance at Mar. 31, 2020 40,423     $ 0     $ 0     77,847     (41,215)   3,791  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock issuances (in shares)       2,015,148                        
Stock issuances 14,021                 14,021            
Stock-based compensation expenses 296                 296            
Share repurchase (in shares)       (233,788)                        
Share repurchase (6,250)                 (6,250)            
Exercise of stock options (in shares)       47,607                        
Exercise of stock options 12                 12            
Net loss (8,753)                       (8,009)   (744)  
Ending balance (in shares) at Jun. 30, 2020       10,132,997     0                  
Ending balance at Jun. 30, 2020 39,749     $ 0     $ 0     85,926     (49,224)   $ 3,047  
Beginning balance (in shares) at Dec. 31, 2020       24,883,024     0                  
Beginning balance at Dec. 31, 2020 95,250     $ 0     $ 0     164,264     (69,014)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation expenses $ 1,550                 1,550            
Issuance of common shares upon vesting of RSUs (in shares) 7,713                              
Founders earnout shares vested (in shares)       570,212                        
Net loss $ (13,765)                       (13,765)      
Common shares issued for exercise of warrants (in shares)       122,639                        
Common shares issued for exercise of warrants 1,410                 1,410            
Ending balance (in shares) at Mar. 31, 2021       25,583,588     0                  
Ending balance at Mar. 31, 2021 84,445     $ 0     $ 0     167,224     (82,779)      
Beginning balance (in shares) at Dec. 31, 2020       24,883,024     0                  
Beginning balance at Dec. 31, 2020 $ 95,250     $ 0     $ 0     164,264     (69,014)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Exercise of stock options (in shares) 40,942                              
Net loss $ (22,721)                              
Ending balance (in shares) at Jun. 30, 2021       25,629,641     0                  
Ending balance at Jun. 30, 2021 78,822     $ 0     $ 0     170,557     (91,735)      
Beginning balance (in shares) at Mar. 31, 2021       25,583,588     0                  
Beginning balance at Mar. 31, 2021 84,445     $ 0     $ 0     167,224     (82,779)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation expenses 3,323                 3,323            
Exercise of stock options (in shares)       40,942                        
Exercise of stock options $ 10                 10            
Issuance of common shares upon vesting of RSUs (in shares) 5,111                              
Net loss $ (8,956)                       (8,956)      
Ending balance (in shares) at Jun. 30, 2021       25,629,641     0                  
Ending balance at Jun. 30, 2021 $ 78,822     $ 0     $ 0     $ 170,557     $ (91,735)